In February, the Trump administration issued an executive order outlining steps for federal agencies to promote healthcare price transparency for patients, employers, and policymakers. In her latest piece for Health Affairs, Stacey Pogue explores how this executive order could improve areas where healthcare price transparency has historically faced challenges.
Peter Nelson, the new director of the Center for Consumer Information and Insurance Oversight (CCIIO) has brought a long forgotten ACA provision back into the spotlight. CHIR’s Stacey Pogue breaks down Section 1333 compacts, what it would mean for consumers, and concerns for implementation.
On March 23, 2025, we celebrated the 15th anniversary of the Affordable Care Act (ACA). In this post, CHIR experts reflect on how the law’s reforms affected people’s access to affordable, high quality health insurance, and what the next 15 years might bring.
Over the last two months, CHIR hosted a three-part webinar series about the corporate transformation of health care. Kennah Watts discusses some unanswered questions from the series relating to price caps, transparency, and rural hospitals, and highlights further CHIR resources on the subject.
In February we stayed out of the cold and bundled up with the latest in health policy research. We read about salary and utilization changes in hospitals acquired by private equity, challenges with price transparency requirements, and changes to hospital community benefit rules in Oregon.
Massachusetts recently enacted a law to increase transparency and oversight of private equity in healthcare following the collapse of Steward Health Care. CHIR experts Stacey Pogue and Kennah Watts break down the law and how it serves as a potential model for other states facing similar challenges with healthcare corporatization.
High and rising healthcare costs in the U.S. are driven largely by escalating hospital prices, fueled by increasing consolidation among health systems. In a recent Issue Brief for the Milbank Memorial Fund, Sabrina Corlette and Karen Davenport discuss what states can do to enhance premium rate review programs, to ultimately curb provider price increases.
Private equity is not new to the health care sector, but recent growth in private equity investment has sparked a plethora of research studies, media attention, and political attention. A recent Congressional investigation and agency report, on top of continuing research indicate the time for policymakers to take action against private equity in health care is now.
Since the snow shows no sign of stopping, we might as well stay cozy inside and read up on the latest health policy research from January! This month we read about patient care after private equity acquisition of hospitals, and how to improve risk-adjustment accuracy in Medicare Advantage.
Like other employer health plans across the commercial insurance market, state employee health plans (SEHPs) regularly face significant increases in health care costs. A new piece by CHIR faculty for Health Affairs explores how SEHPs’ use of provider-based reference pricing to constrain cost growth has been gaining traction.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
